Search research articles
Contact Us
Filters
Showing results (71-80 of 320) with videos related to
Page
of 32
Sort By:
Cancer
|
April 4, 2017
Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma
Mona M Sabra, Eric J Sherman, R Michael Tuttle
The Lancet. Diabetes & Endocrinology
|
November 27, 2015
Management of advanced medullary thyroid cancer
Julien Hadoux, Furio Pacini, R Michael Tuttle, et al.
Otolaryngologic Clinics of North America
|
June 14, 2003
Postoperative management of differentiated thyroid cancer
Erik G Cohen, R Michael Tuttle, Dennis H Kraus
Thyroid : Official Journal of the American Thyroid Association
|
December 6, 2011
In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response
Fernanda Vaisman, Hernan Tala, Ravinder Grewal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2010
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer
James A Fagin, R Michael Tuttle, David G Pfister
Endocrine
|
December 25, 2013
Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies
Eyal Robenshtok, Azeez Farooki, Ravinder K Grewal, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 23, 2014
Response to initial therapy predicts clinical outcomes in medullary thyroid cancer
Susan C Lindsey, Ian Ganly, Frank Palmer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 29, 2015
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma
Juan P Brito, Yasuhiro Ito, Akira Miyauchi, et al.
Journal of the Endocrine Society
|
December 11, 2025
Effect of GLP-1 Receptor Agonists on Patients with Thyroid Carcinomas Undergoing Active Surveillance
Armando Patrizio, Samantha K Newman, R Michael Tuttle, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
March 12, 2016
Ethical Considerations When Counseling Patients With Thyroid Cancer About Surgery vs Observation
Luc G T Morris, Richard J Wong, R Michael Tuttle
Page
of 32
Search research articles
Search
Showing results (71-80 of 320) with videos related to
Sort By:
Page
of 32
Cancer
|
April 4, 2017
Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma
Mona M Sabra, Eric J Sherman, R Michael Tuttle
The Lancet. Diabetes & Endocrinology
|
November 27, 2015
Management of advanced medullary thyroid cancer
Julien Hadoux, Furio Pacini, R Michael Tuttle, et al.
Otolaryngologic Clinics of North America
|
June 14, 2003
Postoperative management of differentiated thyroid cancer
Erik G Cohen, R Michael Tuttle, Dennis H Kraus
Thyroid : Official Journal of the American Thyroid Association
|
December 6, 2011
In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response
Fernanda Vaisman, Hernan Tala, Ravinder Grewal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2010
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer
James A Fagin, R Michael Tuttle, David G Pfister
Endocrine
|
December 25, 2013
Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies
Eyal Robenshtok, Azeez Farooki, Ravinder K Grewal, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 23, 2014
Response to initial therapy predicts clinical outcomes in medullary thyroid cancer
Susan C Lindsey, Ian Ganly, Frank Palmer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 29, 2015
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma
Juan P Brito, Yasuhiro Ito, Akira Miyauchi, et al.
Journal of the Endocrine Society
|
December 11, 2025
Effect of GLP-1 Receptor Agonists on Patients with Thyroid Carcinomas Undergoing Active Surveillance
Armando Patrizio, Samantha K Newman, R Michael Tuttle, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
March 12, 2016
Ethical Considerations When Counseling Patients With Thyroid Cancer About Surgery vs Observation
Luc G T Morris, Richard J Wong, R Michael Tuttle
Page
of 32